Regenerative medicine, although a promising medical field, is controversial. Those who oppose it do so because of religious reasons and perhaps because the stems cells required to perform regenerative medicine procedures could only be obtained from cadavers, but that was in the early days of regenerative medicine.
Bloomberg revealed that presently, the relatively new field has improved drastically courtesy of input from professionals such as Dr. Cameron Clokie. Dr. Clokie has dedicated his career to demonstrating that regenerative medicine is a better alternative to some traditional surgeries of body rebuilding. Learn more about Cameron Clokie: https://www.wingsjournal.com/dr-cameron-clokie-gives-quick-tips-tooth-care-traveling
Also, part of his career is preoccupied with finding new sources of stems cells. For example, Dr. Clokie presently uses bone morphogenetic protein (BMP) produced from the cells of Chinese hamsters. During one of his conferences, Dr. Clokie indicated that plans were underway to produce BMP by incubating a gene producing the protein in the embryos of goats.
Dr. Clokie, an oral and maxillofacial surgeon, has proven that regenerative medicine beats traditional surgery with regards to jaw reconstruction. In the early 2000’s, Dr. Clokie reconstructed Peter Russel’s jaw. The former had lost part of his jaw to a benign tumor. Dr. Clokie used BMP to initiate a jaw bone growth in Russel. The procedure turned out well as Russel developed a new jaw bone with no complications.
During one of his conferences, Dr. Clokie compared Russel experience to Ms. McFarlane’s (another victim of benign tumor who had undergone traditional surgery). While Russel spent only four hours in the operating theatre, and 48 more hours in the hospital, surgeons operated on Ms. McFarlane for over 20 hours.
McFarlane spent over two weeks in the hospital after the surgery. In fact, she was under intensive care unit during the first week. To add insult to injury, McFarlane’s date with the surgeons was not yet over as she was scheduled to be operated on some few months after the first operation. Russel underwent only one procedure, and that was it.
Dr. Clokie is the CEO of Induce Biologics Inc. The regenerative medicine firm seeks to find solutions for patients such as Russel. Dr. Clokie was a professor and in charge of Oral and Maxillofacial Surgery at the University of Toronto until his recent retirement.